| CAS | Product Name | MF |
|
147682-51-7
|
Benzenesulfonyl chloride, 4-hydroxy-3-nitro- (9CI)
|
C6H4ClNO5S
|
|
161876-64-8
|
Benzaldehyde, 4-ethyl-2-hydroxy- (9CI)
|
C9H10O2
|
|
6335-39-3
|
Benzenesulfonamide, 4-(1-methylethyl)- (9CI)
|
C9H13NO2S
|
|
2382-48-1
|
ubichromenol
|
C59H90O4
|
|
89680-17-1
|
H-D-MET-MET-OH
|
C10H20N2O3S2
|
|
78028-01-0
|
CAY10397
|
C17H16N2O5
|
|
1071638-38-4
|
MAC-13243
|
C20H25Cl2N3O2S
|
|
1208075-44-8
|
Ethyl 2-broMo-5-iodobenzoate
|
C9H8BrIO2
|
|
1149388-19-1
|
4-Bromo-3-hydroxy-2-methyl-benzoic acid methyl ester
|
C9H9BrO3
|
|
32082-17-0
|
1-methyl-3-oxocyclobutane-1-carbonitrile
|
C6H7NO
|
|
433249-94-6
|
6877002
|
C17H17NO
|
|
22106-37-2
|
1-(4-PYRROL-1-YL-PHENYL)-ETHANONE
|
C12H11NO
|
|
2070014-82-1
|
Osimertinib dimesylate
|
C29H37N7O5S
|
|
36603-80-2
|
Sodium tricyanomethanide
|
C4N3Na
|
|
77875-68-4
|
BETA-LIPOTROPIN (1-10) (PORCINE)
|
C42H66N10O15
|
|
271780-64-4
|
1-(2-[4-(6-FLUORO-1H-INDOL-3-YL)-3,6-DIHYDRO-2H-PYRIDIN-1-YL]-ETHYL)-3-ISOPROPYL-6-METHANESULFONYL-3,4-DIHYDRO-1H-BENZO[1,2,6]THIADIAZINE 2,2-DIOXIDE
|
C26H31FN4O4S2
|
|
1315378-72-3
|
Scrambled 10Panx
|
C58H79N15O16
|
|
502421-44-5
|
N-t-Boc-valacyclovir
|
C18H28N6O6
|
|
51169-05-2
|
2-hydrazinylpyridine hydrochloride
|
C5H8ClN3
|
|
90937-05-6
|
(P-AMINO-PHE6)-ANGIOTENSIN II
|
C53H74N12O12
|
|
1240516-71-5
|
GSK 2239633A
|
C24H25ClN4O5S2
|
|
34161-23-4
|
FIPEXIDE HYDROCHLORIDE
|
C20H22Cl2N2O4
|
|
2060029-80-1
|
7-(4-chlorobutoxy)-1-{4-[(2-oxo-1,2-dihydroquinolin-7-yl)oxy]butyl}-1,2-dihydroquinolin-2-one
|
C26H27ClN2O4
|
|
55750-02-2
|
TETRACAINE N-OXIDE
|
C15H24N2O3
|
|
1285572-54-4
|
Dotinurad Impurity 11
|
C14H9Cl2NO2S
|
|
61337-87-9
|
(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
|
C17H19N3
|
|
279263-03-5
|
5-BROMO-2-ETHOXY-BENZONITRILE
|
C9H8BrNO
|
|
10491-09-5
|
H-D-ALA-D-ALA-D-ALA-D-ALA-D-ALA-OH
|
C15H27N5O6
|
|
56883-05-7
|
N6-ANISOYLADENOSINE
|
C18H19N5O6
|
|
1226898-27-6
|
(R)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline
|
C29H30FeNOP
|
|
120041-08-9
|
GADOTERIDOL RELATED COMPOUND A (50 MG) (10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODE-CANE-1,4,7-TRIACETIC ACID)
|
C17H32N4O7
|
|
80325-22-0
|
Gypenoside XIII
|
C41H70O12
|
|
873080-25-2
|
4-Pyrimidinecarboxamide, 5-chloro-N-[(4-chlorophenyl)methyl]-2-(ethylsulfonyl)-N-(2-furanylmethyl)-
|
C19H17Cl2N3O4S
|
|
74543-21-8
|
sodium hydrogen 4-aminoazobenzene-3,4'-disulphonate
|
C12H12N3NaO6S2
|
|
17043-94-6
|
PYRIMIDINE N-OXIDE, 97%
|
C4H4N2O
|
|
120042-14-0
|
2(S)-Amino-4-azido-butanoic Acid
|
C4H8N4O2
|
|
194093-42-0
|
N-[(8R)-1-azabicyclo[2.2.2]oct-8-yl]-2-oxo-9-thia-5-azabicyclo[4.3.0]n ona-3,7,10-triene-3-carboxamide hydrochloride
|
C15H18ClN3O2S
|
|
108375-77-5
|
PC 766B
|
C43H68O12
|
|
583-63-1
|
2-benzoquinone
|
C6H4O2
|
|
4185-01-7
|
12-ALPHA-HYDROXY-3-OXO-5-BETA-CHOLANOICACID
|
C24H38O4
|
|
1260783-82-1
|
METHYL 2-BROMO-3-HYDROXYBENZOATE
|
C8H7BrO3
|
|
14355-04-5
|
N-[3-(Trifluoromethyl)benzyl]ethylamine
|
C10H12F3N
|
|
1308278-67-2
|
Cariprazine-d6
|
C21H32Cl2N4O
|
|
81438-51-9
|
ETHYL 2,6-DIMETHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE
|
C12H14N2O2
|
|
186145-08-4
|
3,4-DEHYDRO-L-PROLINE METHYL ESTER HYDROCHLORIDE
|
C6H10ClNO2
|
|
39642-87-0
|
1,3-dipyridin-4-ylurea
|
C11H10N4O
|
|
74605-12-2
|
4-(2,5-DIMETHOXY-PHENYL)-THIAZOL-2-YLAMINE
|
C11H12N2O2S
|
|
73900-07-9
|
METHYL-D3 TRIFLATE
|
C2D3F3O3S
|
|
12111-19-2
|
LB BROTH
|
C14H17CoO6
|
|
68052-47-1
|
oleic acid, compound with 2-(heptadec-8-enyl)-4,5-dihydro-1H-imidazole-1-ethanol (1:1)
|
C40H74N2O2
|
|
869304-55-2
|
Trans-24
|
C26H21N3O3
|
|
944-78-5
|
1,2,4,5-tetrachloro-3,6-dimethoxybenzene
|
C8H6Cl4O2
|
|
197247-23-7
|
DINOR-12-OXO-PHYTODIENOIC ACID (dn-OPDA)
|
C16H24O3
|
|
13745-58-9
|
2,4-DiMethyl-2H-pyrazole-3-carboxylic acid
|
C6H8N2O2
|
|
24078-79-3
|
5-Chloro-2-furoyl chloride
|
C5H2Cl2O2
|
|
1684453-05-1
|
Mirabegron 2-Oxo Impurity
|
C21H22N4O3S
|
|
65115-91-5
|
5 6-EPOXY-5 6-DIHYDRO-(1 10)PHENANTHROL&
|
C12H8N2O
|
|
37470-42-1
|
4'-ETHOXY-2'-HYDROXYACETOPHENONE
|
C10H12O3
|
|
5068-21-3
|
(4-HYDROXYPHENYL)DIPHENYLPHOSPHINE
|
C18H15OP
|
|
105544-30-7
|
5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester
|
C9H9BrN2O5
|
|
1126-62-1
|
(3,4-DIHYDROXYPHENYL)ACETONITRILE
|
C8H7NO2
|
|
1173023-45-4
|
Pyridoxamine-[D3] dihydrochloride (Vitamin B6-[D3])
|
C8H13ClN2O2
|
|
116425-35-5
|
Aerugidiol
|
C15H22O3
|
|
1256833-88-1
|
2-Bromo-4-chloronicotinic acid
|
C6H3BrClNO2
|
|
1621169-52-5
|
Myostatin inhibitory peptide 7
|
C133H227N43O33
|
|
1876450-21-3
|
MM 07
|
C67H106N22O14S3
|
|
7279-75-6
|
4-[1-HYDROXY-2-([1-METHYLETHYL]AMINO)BUTYL]-1,2-BENZENEDIOL METHANESULFONATE
|
C14H25NO6S
|
|
2051921-49-2
|
4-Pyridinamine, 2,6-dichloro-3-fluoro-
|
C5H3Cl2FN2
|
|
2093305-05-4
|
L-Isoleucinamide, O-(phosphono-ÎșO)-N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-
|
C27H45N4O8P
|
|
7344-02-7
|
N-ARACHIDOYL-D-ERYTHRO-SPHINGOSINE
|
C38H75NO3
|
|
14292-44-5
|
5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[D][1,3]THIAZOL-2-AMINE
|
C8H12N2S
|
|
1474-53-9
|
17-BETA-ESTRADIOL 3-METHYL ETHER
|
C19H26O3
|
|
853652-40-1
|
CAY10573
|
C33H31NO5
|
|
254110-79-7
|
CEF27
|
C51H82N16O14
|
|
1539285-81-8
|
(R)-3,3'-Bis([1,1':3',1''-terphenyl]-5'-yl)-[1,1'-binaphthalene]-2,2'-diol
|
C56H38O2
|
|
74665-17-1
|
TITANIUM(IV) (TRIETHANOLAMINATO)ISOPROPOXIDE
|
C9H19NO3Ti
|
|
6915-68-0
|
2-(9H-CARBAZOL-9-YL)ETHYL ACRYLATE 97
|
C17H15NO2
|
|
1449598-85-9
|
7-fluoro-2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one
|
C8H5FN2O2
|
|
2153433-46-4
|
1,4-Benzenedicarbonitrile, 2,3,5,6-tetrakis[3,6-bis(1,1-dimethylethyl)-9H-carbazol-9-yl]-
|
C88H96N6
|
|
98437-41-3
|
5-BROMO-2-HYDROXY-4-METHOXYBENZOIC ACID
|
C8H7BrO4
|
|
1824637-41-3
|
1H-Benzimidazole-6-carboxamide, 1-ethyl-2-(hydroxydiphenylmethyl)-N-[(2R)-2-hydroxypropyl]-
|
C26H27N3O3
|
|
57905-31-4
|
4-HYDROXY-NICOTINIC ACID ETHYL ESTER
|
C8H9NO3
|
|
74545-79-2
|
Aloeresin A
|
C28H28O11
|
|
2266-41-3
|
4-FLUOROBENZENESULFONOHYDRAZIDE
|
C6H7FN2O2S
|
|
29415-71-2
|
6-(diethylamino)-2,3-dihydrophthalazine-1,4-dione
|
C12H15N3O2
|
|
34438-27-2
|
ENDURACIDIN A
|
C107H138Cl2N26O31
|
|
371934-59-7
|
PIK-inhibitors
|
C19H17N5O2
|
|
1952316-43-6
|
R-Acalabrutinib
|
C26H23N7O2
|
|
1627607-88-8
|
(S)-PFI-2 (hydrochloride)
|
C23H26ClF4N3O3S
|
|
25597-09-5
|
STEAROYL-L-CARNITINE
|
C25H49NO4
|
|
1567335-29-8
|
Cav 2.2 blocker 1
|
C25H29ClN2O2
|
|
54732-89-7
|
2H-Benzimidazol-2-one,5-amino-1,3-dihydro-1-methyl-(9CI)
|
C8H9N3O
|
|
18361-46-1
|
Leucomycin A4
|
C41H67NO15
|
|
1347750-20-2
|
Thiol-PEG5-Amine
|
C12H27NO5S
|
|
1831830-20-6
|
IL-15-IN-1
|
C30H36N6O4S
|
|
99473-11-7
|
N-DESMETHYLTERBINAFINE
|
C20H23N
|
|
1301706-63-7
|
(9H-Fluoren-9-yl)MethOxy]Carbonyl N-Me-D-Ile-OH
|
C22H25NO4
|
|
1228765-67-0
|
2,4-Dihydro-5-methyl-2-(phenyl-2,3,4,5,6-d5)-3H-pyrazol-3-one
|
C10H10N2O
|
|
2177287-68-0
|
Carfilzomib Impurity 35
|
C14H25NO4
|
|
5022-48-0
|
5-CHLORO-2-HYDROXY-BENZOIC ACID HYDRAZIDE
|
C7H7ClN2O2
|